PODD - インスレット (Insulet Corporation)

PODDのニュース

   Europe Continuous Glucose Monitoring Systems Market 2021 Global Industry Analysis by Top Key Players,Types, Key Regions Demand and Future Growth till 2027 | Echo Therapeutics Inc., Insulet Corporation, Johnson & Johnson, Medtronic plc, Senseonics Holding  2021/03/17 13:37:26 OpenPR
Europe Continuous Glucose Monitoring Systems Market Report, published by Allied Market Research, forecasts that the market was valued $58 million in 2015, and is expected to reach $792 million by 2027, supported by a CAGR of 44.9% during the forecast
   Insulet Reports Full Year 2020 Revenue Increase of 23% and Fourth Quarter 2020 Revenue Increase of 18% Year-Over-Year  2021/02/23 21:01:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced financial results for the three months and full year ended December 31, 2020. Full Year Financial Highlights: Full Year 2020 revenue of $904.4 million, up 22.5%, or 21.9% in constant currency1, compared to $738.2 million in the prior year, exceeds guidance of 20% to 21% on a
   Europe Wearable Injectors Market Set to Expand by 2020-2027 Focusing on Key Players BD, CeQur SA, Debiotech S.A, Insulet Corporation, Gerresheimer AG, Amgen, Inc  2021/02/23 09:18:33 OpenPR
The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027. Get Sample Copy of this
   Tubeless Insulin Pump Market With Leading Players like Insulet Corporation, Johnson and Johnson, Medtrum Technologies Inc., Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA Valeritas, Abbott Diabetes Care  2021/02/23 08:20:30 OpenPR
An off-the-shelf report on Tubeless Insulin Pump Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such
   Insulet Earnings Report: Here’s what to expect from Stock market Insights & financial analysis  2021/02/22 12:25:00 Stock Market Daily
Insulet announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Europe Continuous Glucose Monitoring Systems Market 2021 Global Industry Analysis by Top Key Players,Types, Key Regions Demand and Future Growth till 2027 | Echo Therapeutics Inc., Insulet Corporation, Johnson & Johnson, Medtronic plc, Senseonics Holding  2021/03/17 13:37:26 OpenPR
Europe Continuous Glucose Monitoring Systems Market Report, published by Allied Market Research, forecasts that the market was valued $58 million in 2015, and is expected to reach $792 million by 2027, supported by a CAGR of 44.9% during the forecast
   Insulet Reports Full Year 2020 Revenue Increase of 23% and Fourth Quarter 2020 Revenue Increase of 18% Year-Over-Year  2021/02/23 21:01:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced financial results for the three months and full year ended December 31, 2020. Full Year Financial Highlights: Full Year 2020 revenue of $904.4 million, up 22.5%, or 21.9% in constant currency1, compared to $738.2 million in the prior year, exceeds guidance of 20% to 21% on a
   Europe Wearable Injectors Market Set to Expand by 2020-2027 Focusing on Key Players BD, CeQur SA, Debiotech S.A, Insulet Corporation, Gerresheimer AG, Amgen, Inc  2021/02/23 09:18:33 OpenPR
The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027. Get Sample Copy of this
   Tubeless Insulin Pump Market With Leading Players like Insulet Corporation, Johnson and Johnson, Medtrum Technologies Inc., Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA Valeritas, Abbott Diabetes Care  2021/02/23 08:20:30 OpenPR
An off-the-shelf report on Tubeless Insulin Pump Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such
   Insulet Earnings Report: Here’s what to expect from Stock market Insights & financial analysis  2021/02/22 12:25:00 Stock Market Daily
Insulet announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Insulet Reports Full Year 2020 Revenue Increase of 23% and Fourth Quarter 2020 Revenue Increase of 18% Year-Over-Year  2021/02/23 21:01:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced financial results for the three months and full year ended December 31, 2020. Full Year Financial Highlights: Full Year 2020 revenue of $904.4 million, up 22.5%, or 21.9% in constant currency1, compared to $738.2 million in the prior year, exceeds guidance of 20% to 21% on a
   Europe Wearable Injectors Market Set to Expand by 2020-2027 Focusing on Key Players BD, CeQur SA, Debiotech S.A, Insulet Corporation, Gerresheimer AG, Amgen, Inc  2021/02/23 09:18:33 OpenPR
The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027. Get Sample Copy of this
   Tubeless Insulin Pump Market With Leading Players like Insulet Corporation, Johnson and Johnson, Medtrum Technologies Inc., Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA Valeritas, Abbott Diabetes Care  2021/02/23 08:20:30 OpenPR
An off-the-shelf report on Tubeless Insulin Pump Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such
   Insulet Earnings Report: Here’s what to expect from Stock market Insights & financial analysis  2021/02/22 12:25:00 Stock Market Daily
Insulet announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings  2021/02/20 14:36:28 Benzinga
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before picking up pace in the unfolding week. Bluebird bio Inc (NASDAQ: BLUE ) was among the worst performers of the week after the company temporarily stalled its gene therapy studies in sickle cell disease. A day after bluebird bio shared the negative tidings, Novartis AG (NYSE: NVS ) announced an agreement with the Bill & Melinda Gates Foundation for funding the development of a single-administration, in-vivo gene therapy to cure sickle cell disease. The week also witnessed the forging of a few alliances and partnerships, a slew of follow-on offerings and some vaccine updates. Here are the key catalytic events for the coming week: Conferences: Annual SVB Leerink Global Healthcare Conference (virtual event): Feb. 22-26 Citi Healthcare Services Virtual Conference (virtual event): Feb. 24-25 Americas Committee for Treatment and Research in Multiple Sclerosis, or ACTRIMS, Forum (virtual event): Feb. 25-27 PDUFA Dates The Food and Drug Administration is scheduled to rule on Sarepta Therapeutics Inc's (NASDAQ: SRPT ) new drug application for casimersen, a treatment for patients with Duchenne muscular dystrophy who have certain genetic mutations.

calendar